The elevated levels of p-Smad2 and p-Smad3 in patients with GC compared with HCs further support the hypothesis that Megasphaera may be involved in GC-related TGF-β/Smad2/3 signalling. The gene discussed is SMAD2; the disease is gastric cancer.